SIO is pleased to provide its updated clinical practice guidelines for breast cancer. In June 2018, ASCO announced endorsement of the guidelines. The guidelines were published in 2017. Researchers analyzed which integrative treatments are most effective and safe for patients with breast cancer. The guidelines are a resource for clinicians and patients to inform evidence-based decisions on the use of integrative therapies during breast cancer treatment. Researchers at US and Canadian institutions evaluated the efficacy and safety of more than 80 therapies.
The Journal of the National Cancer Institute Monograph has published a special issue co-sponsored by SIO, "Advancing the Global Impact of Integrative Oncology"; including a comprehensive definition for integrative oncology. The articles in the special Monograph were all peer-reviewed.
The Society for Integratice Oncology (SIO) is committed to developing talented young investigators in integrative oncology with its New Investigator Forum on Integrative Oncology Research Methods. We are now accepting New Investigator Forum applications for the 16th International Conference that will be held in New York, NY, October 19-21. Read more here: New Investigator 2019
Please mark your calendars to join us for the 16th International Conference October 19-21, 2019 in New York, NY. The conference theme: Advancing the Science and Art of Integrative Oncology.
Thank You for SIO2018! We thank the more than 400 participants for making SIO's 15th International Conference, October 27-29, 2018 in Scottsdale, Arizona, so successful. We appreciate all the great converations and sharing of experience.
SIO2019 Call for Abstracts is open for submissions until April 26, 2019 at 11:59 pm (ET) and notifications will be sent in June 2019.
The 16th International Conference of the Society for Integrative Oncology (SIO) will be held October 19-21, 2019 in New York City, New York, USA. The theme is "Integrative Oncology: Advancing the Science & Art of Integrative Oncology."
To submit your abstract, click here.